As of May 2023, Ozempic and Wegovy are both listed on FDAs Drug Shortages list . When reached for comment on the matter, Novo Nordisk pointed to this press release concerning its recent filing of trademark infringement and false advertising suits against certain medical spas, weight loss or wellness clinics, and compounding pharmacies, that it alleges are unlawfully using its trademarked brand names Ozempic or Wegovy when marketing and/or selling compounded products purporting to contain semaglutide that are not genuine Ozempic or Wegovy products
Finally, theres the accountability factor: knowing you have scheduled check-ins with a doctor keeps motivation high and makes it easier to stay consistent
Depending on your plans deductible, you might pay the full cost to fill a prescription
Alzheimer's disease as type 3 diabetes: common pathophysiological mechanisms between Alzheimer's disease and type 2 diabetes
Without specific proof as to the exact cause of why a GLP-1 could cause a higher risk of developing NAION, we can hypothesize a bit and suggest hypovolemia and dehydration from perhaps weight loss, especially if the patient is getting a medication for hypertension and the weight loss has reduced the need for the hypertensive agent and thus the patient develops hypotension
Steinberg MH (2020) Treating sickle cell anemia: a new era dawns
